Antibiotice Income Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	658.06	686.13	614.16	497.5	376.76
Other Revenue	1.98	2.57	1.12	7.5	2.07
Revenue	660.04	688.7	615.29	505	378.83
Revenue Growth (YoY)	-4.16%	11.93%	21.84%	33.31%	9.10%
Cost of Revenue	259.54	254.42	232.64	187.45	146.97
Gross Profit	400.5	434.28	382.65	317.55	231.86
Selling, General & Admin	204.62	198.64	161.69	130.53	125.92
Other Operating Expenses	72.11	83.39	95.66	91.94	47.57
Operating Expenses	329.73	327.09	285.23	244.73	197.61
Operating Income	70.77	107.19	97.42	72.81	34.25
Interest Expense	-4.47	-4.54	-4.15	-3.59	-3.52
Interest & Investment Income	0	0	0	0	0
Currency Exchange Gain (Loss)	-6.42	0.26	-0.95	-0.8	-0.22
Other Non Operating Income (Expenses)	0.21	0.04	0.08	-0.18	-0.21
EBT Excluding Unusual Items	60.09	102.95	92.42	68.25	30.3
Gain (Loss) on Sale of Assets	0.05	0.16	0	0.1	-
Asset Writedown	-	-	-0.9	-3.04	-
Pretax Income	60.15	103.11	91.52	65.31	30.3
Income Tax Expense	8.38	0.91	10.44	13.84	0.36
Net Income	51.77	102.2	81.09	51.47	29.94
Net Income to Common	51.77	102.2	81.09	51.47	29.94
Net Income Growth	-49.35%	26.04%	57.54%	71.92%	13.46%
Shares Outstanding (Basic)	671	671	671	671	671
Shares Outstanding (Diluted)	671	671	671	671	671
EPS (Basic)	0.08	0.15	0.12	0.08	0.04
EPS (Diluted)	0.08	0.15	0.12	0.08	0.04
EPS Growth	-49.35%	26.04%	57.54%	71.92%	13.46%
Free Cash Flow	-70.17	-3.63	39.43	78.09	15.39
Free Cash Flow Per Share	-0.10	-0.01	0.06	0.12	0.02
Dividend Per Share	0.036	0.021	0.083	0.008	0.003
Dividend Growth	74.05%	-75.21%	946.74%	147.72%	-3.27%
Gross Margin	60.68%	63.06%	62.19%	62.88%	61.20%
Operating Margin	10.72%	15.56%	15.83%	14.42%	9.04%
Profit Margin	7.84%	14.84%	13.18%	10.19%	7.90%
Free Cash Flow Margin	-10.63%	-0.53%	6.41%	15.46%	4.06%
EBITDA	124.98	152.24	125.35	95.38	58.68
EBITDA Margin	18.93%	22.11%	20.37%	18.89%	15.49%
D&A For EBITDA	54.2	45.06	27.93	22.57	24.43
EBIT	70.77	107.19	97.42	72.81	34.25
EBIT Margin	10.72%	15.56%	15.83%	14.42%	9.04%
Effective Tax Rate	13.93%	0.88%	11.40%	21.19%	1.20%
Advertising Expenses	22.63	27.51	-	-	11.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.